SEC Form DEF 14A filed by AMN Healthcare Services Inc
$AMN
Professional Services
Consumer Discretionary
Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/8/2024 | Outperform → Mkt Perform | William Blair | |
| 10/7/2024 | $65.00 → $48.00 | Neutral → Underperform | BofA Securities |
| 12/6/2023 | $85.00 | Mkt Outperform | JMP Securities |
| 11/3/2023 | $115.00 → $70.00 | Buy → Hold | Jefferies |
| 11/3/2023 | Buy → Hold | The Benchmark Company | |
| 8/4/2023 | $112.00 → $104.00 | Buy → Neutral | BofA Securities |
| 2/18/2022 | $140.00 → $170.00 | Buy | Jefferies |
| 2/18/2022 | $125.00 → $140.00 | Buy | Benchmark |
DALLAS, May 12, 2025 (GLOBE NEWSWIRE) -- While 75% of nurses report being satisfied with their career choice, many still face significant strain due to burnout, mental health challenges, and staffing issues, according to a new survey by AMN Healthcare, the leader and innovator in total talent solutions for healthcare organizations. More than half of nurses (58%) report feeling burnout most days, and only 39% plan to be in their current positions in 12 months. The remaining 61% plan to change jobs or departments, seek a hybrid position, work as travelers, or make other career changes. AMN Healthcare's 2025 Survey of Registered Nurses measures the insights and direction of the nursing profe
Quarterly revenue of $690 million; GAAP loss of ($0.03)/share and adjusted EPS of $0.45 DALLAS, May 08, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its first quarter 2025 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts. Q1 2025% Change Q1 2024Revenue$689.5(16%)Gross profit$198.1(23%)Net loss($1.1)nmDiluted loss per share($0.03)nmAdjusted diluted EPS*$0.45(54%)Adjusted EBITDA*$64.2(34%) * See "Non-GAAP Measures" below for a discussion of our use of non-GAAP items and the table entitled "
DALLAS, April 08, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), has scheduled a conference call to discuss its first quarter 2025 financial results and second quarter 2025 outlook on Thursday, May 8, 2025, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time. A live webcast of the call can be accessed through this webcast link, which also will be available on AMN Healthcare's investor relations website. Interested parties may participate live via telephone by registering at this conference call link. Please follow the link and register with a valid e-mail addre
SCHEDULE 13G/A - AMN HEALTHCARE SERVICES INC (0001142750) (Subject)
8-K - AMN HEALTHCARE SERVICES INC (0001142750) (Filer)
S-8 - AMN HEALTHCARE SERVICES INC (0001142750) (Filer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
SC 13G/A - AMN HEALTHCARE SERVICES INC (0001142750) (Subject)
SC 13G/A - AMN HEALTHCARE SERVICES INC (0001142750) (Subject)
SC 13G/A - AMN HEALTHCARE SERVICES INC (0001142750) (Subject)
William Blair downgraded AMN Healthcare from Outperform to Mkt Perform
BofA Securities downgraded AMN Healthcare from Neutral to Underperform and set a new price target of $48.00 from $65.00 previously
JMP Securities initiated coverage of AMN Healthcare with a rating of Mkt Outperform and set a new price target of $85.00
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
DALLAS, Oct. 31, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE:AMN), the leader and innovator in total talent solutions for healthcare organizations, today announced the appointment of Tomya Watt as Chief People Officer effective January 13, 2025. With more than two decades of strategic and operational experience in healthcare and talent solutions, Ms. Watt is well-equipped to guide the company's human resources function into a new era of sustainable growth. "We are thrilled to welcome Tomya Watt to AMN Healthcare," said Cary Grace, AMN Healthcare's President and CEO. "Our exceptional team and culture distinguish us in the industry. Tomya's visionary leadership and extensive expertise
DALLAS, Oct. 03, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN) ("AMN" or "the Company"), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced that Brian Scott has been appointed Chief Financial Officer and Chief Operating Officer, effective November 21, 2024. In this role, Mr. Scott will be responsible for AMN's finance and enterprise operating functions as the Company continues to evolve its model to be more automated and scaled. Mr. Scott is returning to AMN, where he previously held a variety of roles of increasing responsibility in finance, strategy and accounting over his 17-year tenure, includin
DALLAS, July 31, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE:AMN) is taking steps to further strengthen its market-leading approach to total talent solutions in healthcare by creating a new Executive Advisory Board, which will be led by Mike Butler, former President of Providence. Consisting of accomplished leaders from various healthcare organizations, the Executive Advisory Board will serve as trusted advisors, leveraging their extensive industry expertise to unlock new market opportunities. Their work will center on ways to help healthcare organizations optimize their workforce planning and management. By deploying predictive analytics and workforce expertise, for example, health
Quarterly revenue of $690 million; GAAP loss of ($0.03)/share and adjusted EPS of $0.45 DALLAS, May 08, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its first quarter 2025 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts. Q1 2025% Change Q1 2024Revenue$689.5(16%)Gross profit$198.1(23%)Net loss($1.1)nmDiluted loss per share($0.03)nmAdjusted diluted EPS*$0.45(54%)Adjusted EBITDA*$64.2(34%) * See "Non-GAAP Measures" below for a discussion of our use of non-GAAP items and the table entitled "
DALLAS, April 08, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), has scheduled a conference call to discuss its first quarter 2025 financial results and second quarter 2025 outlook on Thursday, May 8, 2025, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time. A live webcast of the call can be accessed through this webcast link, which also will be available on AMN Healthcare's investor relations website. Interested parties may participate live via telephone by registering at this conference call link. Please follow the link and register with a valid e-mail addre
Quarterly revenue of $735 million;GAAP loss of ($4.90)/share and adjusted EPS of $0.75 DALLAS, Feb. 20, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its fourth quarter and full year 2024 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts. Q4 2024% Change Q4 2023Full Year 2024% Change Full Year 2023Revenue$734.7 (10%)$2,983.8 (21%)Gross profit$219.0 (16%)$919.4 (26%)Net income (loss)$(187.5) nm $(147.0) nm Diluted earnings (loss) per share$(4.90) nm $(3.85) nm Adjusted diluted EPS*$0.75 (43%